摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3,5-三氮杂螺[5.5]十一碳-1,3-二烯-2,4-二胺 | 76766-46-6

中文名称
1,3,5-三氮杂螺[5.5]十一碳-1,3-二烯-2,4-二胺
中文别名
——
英文名称
1,3,5-Triazaspiro<5.5>undeca-1,3-dien-2,4-diamin
英文别名
1,3,5-Triazaspiro[5.5]undeca-1,3-diene-2,4-diamine;1,3,5-triazaspiro[5.5]undeca-1,4-diene-2,4-diamine
1,3,5-三氮杂螺[5.5]十一碳-1,3-二烯-2,4-二胺化学式
CAS
76766-46-6
化学式
C8H15N5
mdl
——
分子量
181.241
InChiKey
CRKFVFNBXQJZJB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.4
  • 重原子数:
    13
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    88.8
  • 氢给体数:
    3
  • 氢受体数:
    2

反应信息

  • 作为产物:
    参考文献:
    名称:
    �ber substituierte 1,6-Dihydro-1,3,5-triazin-2,4-diamine, 1?,5?,6?,7?-Tetrahydrospiro[cyclopentan-1,4?-cyclopentapyrimidin]-2?(3? H)-imine und das 6-Phenyl-2,4-pyrimidindiamin
    摘要:
    DOI:
    10.1007/bf00909677
点击查看最新优质反应信息

文献信息

  • WENDELIN W.; ZMOELNIG I.; SCHRAMM H.-W., MONATSH. CHEM., 1980, 111, NO 5, 1189-1202
    作者:WENDELIN W.、 ZMOELNIG I.、 SCHRAMM H.-W.
    DOI:——
    日期:——
  • Chemical Inhibitors of Inhibitors of Differentiation
    申请人:CHAUDHARY Jaideep
    公开号:US20090226422A1
    公开(公告)日:2009-09-10
    The present invention provides identification of inhibitors of inhibitors of differentiation (Id) for use in the treatment and prevention of diseases in mammals. The inhibitors of Id are effective alone in the treatment of a variety of cellular proliferative disorders including, but not limited to, diseases such as cancer, arthritis, age-related macular degeneration, psoriasis, neoplasms, angiomas, endometriosis, obesity, age-related macular degeneration, retinopathies, restenosis, scaring, fibrogenesis, fibrosis, cardiac remodeling, pulmonary fibrosis, scleroderma, failure associated with myocardial infarction, keloids, fibroid tumors and stenting. Additionally, these compounds are effective in blocking angiogenesis in tumor development, inducing apoptosis in malignant cells, inhibiting proliferation of cancer cells, increasing the effectiveness of chemotherapeutic agents, regulating transcriptional activity, reducing inflammation, increasing cellular differentiation, modulating ETS domain transcription factors, modulating PAX transcription factors, modulating TCF-ETS domain transcription factors, down regulating RAF-1/MAPK, upregulating JNK signaling pathways, and modulating cellular transformation.
  • US8138356B2
    申请人:——
    公开号:US8138356B2
    公开(公告)日:2012-03-20
  • �ber substituierte 1,6-Dihydro-1,3,5-triazin-2,4-diamine, 1?,5?,6?,7?-Tetrahydrospiro[cyclopentan-1,4?-cyclopentapyrimidin]-2?(3? H)-imine und das 6-Phenyl-2,4-pyrimidindiamin
    作者:Winfried Wendelin、Ilse Zm�lnig、Hans-Wolfgang Schramm
    DOI:10.1007/bf00909677
    日期:——
查看更多